Citation only
via OpenAlex
Immunosenescence and Immunogenetics of Human Longevity
Rita Ostan, L. Bucci, Miriam Capri, Stefano Salvioli, Maria Scurti, E. Pini, Daniela Monti, Claudio Franceschi
NeuroImmunoModulation · 2008 · ▲ 190 citations
Abstract
At present, individuals can live up to 80-120 years, a time much longer than that of our ancestors, as a consequence of the improvements in life conditions and medical care. Thus, the human immune system has to cope with a lifelong and evolutionarily unpredicted exposure to a variety of antigens, which are at the basis of profound age-related changes globally indicated as immunosenescence, a multifaceted phenomenon that increases morbidity and mortality due to infections and age-related pathologies. The major changes occurring during immunosenescence are the result of the accumulation of cellular, molecular defects and involutive phenomena (such as thymic involution) occurring concomitantly to a hyperstimulation of both innate and adaptive immunity (accumulation of expanded clones of memory and effector T cells, shrinkage of the T cell receptor repertoire, progressive activation of macrophages), and resulting in a low-grade, chronic state of inflammation defined as inflammaging(definition). It is unknown whether inflammaging, which represents a risk factor for most age-related pathologies, is a cause or rather an effect of the aging process. In this complex scenario, the role of genetic background likely represents a fundamental variable to attain successful aging and longevity. Accordingly, centenarians seem to be equipped with gene variants that allow them to optimize the balance between pro- and anti-inflammatory molecules, and thus to minimize the effects of the lifelong exposure to environmental insults and stressors. The remarkable features of the genetics of aging and longevity are reviewed, stressing the unexpected and unusual results obtained regarding such a postreproductive type of genetics.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1159/000156466
- Canonical
- link ↗
- Fetched
- 2026-10-02 MST
Cite this
APA
Ostan, R., Bucci, L., Capri, M., Salvioli, S., Scurti, M., Pini, E., Monti, D., & Franceschi, C. (2008). Immunosenescence and Immunogenetics of Human Longevity. <em>NeuroImmunoModulation</em>. https://doi.org/10.1159/000156466
Vancouver
Ostan R, Bucci L, Capri M, Salvioli S, Scurti M, Pini E, et al. Immunosenescence and Immunogenetics of Human Longevity. NeuroImmunoModulation. 2008. doi:10.1159/000156466.
BibTeX
@article{rita2008Immuno,
title = {Immunosenescence and Immunogenetics of Human Longevity},
author = {Rita Ostan and L. Bucci and Miriam Capri and Stefano Salvioli and Maria Scurti and E. Pini and Daniela Monti and Claudio Franceschi},
journal = {NeuroImmunoModulation},
year = {2008},
doi = {10.1159/000156466},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Biochemical and Molecular Toxicology 2024
Citation only
Autophagy in the Cellular Consequences of Tobacco Smoking: Insights into Senescence
Investigative ophthalmology & visual science 2026
Open access · OA
Single-Cell Transcriptomic Analysis Reveals Age-Associated Cellular and Transcriptional Changes in Murine Lacrimal Glands.
Cellular and Molecular Life Sciences 2019
Open access · CC-BY
Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency
International Journal of Molecular Sciences 2022
Open access · CC-BY
The Role of Immunosenescence in Cerebral Small Vessel Disease: A Review
Immunological investigations 2026
Citation only
Pharmacological Modulation of Immunosenescence and Inflammaging: Senolytics, Senomorphics, and Emerging Therapies.
Immunological Investigations 2026
Citation only